PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 199 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $118,628,000 | -32.6% | 2,239,098 | -2.3% | 2.02% | -23.6% |
| Q4 2015 | $175,927,000 | +45.0% | 2,291,010 | -22.4% | 2.64% | +59.5% |
| Q3 2015 | $121,302,000 | +179.0% | 2,951,384 | +380.1% | 1.66% | +169.0% |
| Q2 2015 | $43,478,000 | +226.8% | 614,800 | +309.7% | 0.62% | +227.7% |
| Q4 2014 | $13,306,000 | -67.0% | 150,072 | -65.8% | 0.19% | -70.0% |
| Q2 2014 | $40,264,000 | -44.1% | 438,318 | -57.4% | 0.63% | -46.4% |
| Q1 2014 | $72,090,000 | +10.0% | 1,030,000 | -9.6% | 1.17% | -9.3% |
| Q4 2013 | $65,539,000 | +38.4% | 1,140,000 | +15.7% | 1.29% | +19.8% |
| Q3 2013 | $47,369,000 | -18.7% | 985,000 | -51.0% | 1.07% | -21.1% |
| Q2 2013 | $58,290,000 | – | 2,010,000 | – | 1.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |